Corticosteroids for Dengue - Why Don't They Work?

PLoS Neglected Tropical Diseases

Volumn 7, Issue 12, 2013, Pages

  Nguyen, Thi Hanh Tien ^a   Nguyen, Than Ha Quyen ^a   Vu, Tuan Trung ^a   Farrar, Jeremy ^a,b   Hoang, Truong Long ^c   Dong, Thi Hoai Tam ^d   Ngoc Tran, Van ^d   Phung, Khanh Lam ^a   Wolbers, Marcel ^a,b   Whitehead, Stephen S ^e   Hibberd, Martin L ^c   Wills, Bridget ^a,b   Simmons, Cameron P ^a,b,f  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PLACEBO; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DENGUE; DRUG MEGADOSE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; LOW DRUG DOSE; MALE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; DENGUE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; KILLER CELLS, NATURAL; MALE; PLACEBOS; PREDNISOLONE; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT FAILURE; VIETNAM; YOUNG ADULT;

EID: 84892760430     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002592     Document Type: Article

References (17)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504-507.
2. Rothman AL, (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532-543.
3. Tam DT, Ngoc TV, Tien NT, Kieu NT, Thuy TT, et al. (2012) Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 55: 1216-1224.
4. Hoang LT, Lynn DJ, Henn M, Birren BW, Lennon NJ, et al. (2010) The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol 84: 12982-12994.
5. Sumarmo, Talogo W, Asrin A, Isnuhandojo B, Sahudi A, (1982) Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 69: 45-49.
6. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S, (1993) Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 92: 111-115.
7. Flammer JR, Dobrovolna J, Kennedy MA, Chinenov Y, Glass CK, et al. (2010) The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol Cell Biol 30: 4564-4574.
8. Singh Nikhil JR, Jane Tucker M, (2004) Mechanisms of glucocorticoid-mediated antiinflammatory and immunosuppressive action. Paediatric and Perinatal Drug Therapy 6: 107-115.
9. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, et al. (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189: 221-232.
10. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179: 755-762.
11. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185: 1213-1221.
12. Baumann H, Prowse KR, Marinkovic S, Won KA, Jahreis GP, (1989) Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann N Y Acad Sci 557: 280-295 discussion 295-286.
13. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, et al. (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67: 97-103.
14. Muller B, Peri G, Doni A, Perruchoud AP, Landmann R, et al. (2002) High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol 72: 643-649.
15. Nakagawa M, Terashima T, D'Yachkova Y, Bondy GP, Hogg JC, et al. (1998) Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation 98: 2307-2313.
16. Liu L, Wang YX, Zhou J, Long F, Sun HW, et al. (2005) Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflamm Res 54: 37-41.
17. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, et al. (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193: 1078-1088.